check_circleStudy Completed

Contraception

Bayer Identifier:

14555

ClinicalTrials.gov Identifier:

NCT01319500

EudraCT Number:

Not Available

EU CT Number:

Not Available
Drug Utilzation Study in Croatia

Trial purpose

The primary objective of the study was to characterize the prescribing behaviors for Yasmin® and other oral contraceptives (OCs) in Croatia.

Key Participants Requirements

Sex

Female

Age

NaN - N/A
  • Women prescribed oral contraceptives (OC) between February 16th, 2009 and March 15th, 2009 in Croatia.

Trial summary

Enrollment Goal
N/A
Trial Dates
February 2009 - May 2009
Phase
N/A
Could I Receive a placebo
N/A
Products
Yasmin (EE30/DRSP, BAY86-5131)
Accepts Healthy Volunteer
N/A

Primary Outcome

  • Prescribing indications for Yasmin® and other OCs in Croatia
  • Off-label use of Yasmin® and other OCs in Croatia
  • Current market share of Yasmin® in Croatia

Trial design

Drug Utilization Study on the Prescribing Indications for Yasmin® and Other OCs in Croatia
Trial Type
Observational
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.